Niaouli essential oil (NEO), derived from Melaleuca quinquenervia, possesses bioactive properties attributed mainly to 1,8-cineole; however, its therapeutic application is limited by poor water solubility and chemical instability. In this study, one-step nanoliposomal formulations were developed using hydroxypropyl-β-cyclodextrin (HPβCD) and Tween 80 as stabilizers to improve the bioavailability, antibacterial, and antioxidant activities of NEO. The chemical composition of NEO was characterized using gas chromatography–mass spectrometry (GC-MS). Nanoliposomes (NL1, NL2 with 0.05 % HPβCD, NL3 with 1% Tween 80) were produced through homogenization and analyzed by field emission scanning electron microscopy (FESEM), Fourier-transform infrared spectroscopy (FT-IR), and dynamic light scattering (DLS). The antibacterial activity against Escherichia coli and Staphylococcus aureus was evaluated using agar diffusion and microbroth dilution assays, whereas the antioxidant capacity was determined utilizing DPPH and ABTS methods.
NEO-NL2 exhibited the highest encapsulation efficiency (88.3%) and demonstrated the most potent antibacterial activity, with MIC values of 5.24 mg/mL against E. coli and 1.52 mg/mL against S. aureus. Additionally, adding HPβCD and Tween 80 also improved the antioxidant performance of the formulations.
Overall, these findings indicate that one-step nanoliposomal systems offer an effective and biocompatible delivery platform for essential oils, representing a more straightforward and scalable alternative to complex nanosystems for enhancing antibacterial and antioxidant activities.
If you have any questions about submitting your review, please email us at [email protected].